Janssen Biotech Inc.

02/09/2024 | Press release | Distributed by Public on 02/09/2024 07:18

Johnson & Johnson highlights innovation in hemolytic disease of the fetus and newborn (HDFN) at the Society for Maternal-Fetal Medicine’s (SMFM) 2024 Pregnancy Meeting